Literature DB >> 15164871

Integrin signaling in cancer.

Hira Lal Goel1, Lucia R Languino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164871     DOI: 10.1007/1-4020-7847-1_2

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


× No keyword cloud information.
  12 in total

1.  Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

Authors:  Shihua Sun; Cynthia C T Sprenger; Robert L Vessella; Kathleen Haugk; Kathryn Soriano; Elahe A Mostaghel; Stephanie T Page; Ilsa M Coleman; Holly M Nguyen; Huiying Sun; Peter S Nelson; Stephen R Plymate
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

2.  Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma.

Authors:  Shinichi Sakamoto; Steven Schwarze; Natasha Kyprianou
Journal:  Eur Urol       Date:  2011-01-12       Impact factor: 20.096

Review 3.  Targeting anoikis resistance in prostate cancer metastasis.

Authors:  Shinichi Sakamoto; Natasha Kyprianou
Journal:  Mol Aspects Med       Date:  2010-02-11

4.  Ligand-mimetic anti-alphaIIb beta3 antibody PAC-1 inhibits tyrosine signaling, proliferation and lung colonization of melanoma cells.

Authors:  Erzsébet Rásó; József Tóvári; Andrea Ladányi; Norbert Varga; József Tímár
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

Review 5.  Anoikis and EMT: Lethal "Liaisons" during Cancer Progression.

Authors:  Zheng Cao; Theodore Livas; Natasha Kyprianou
Journal:  Crit Rev Oncog       Date:  2016

6.  Trask loss enhances tumorigenic growth by liberating integrin signaling and growth factor receptor cross-talk in unanchored cells.

Authors:  Danislav S Spassov; Ching Hang Wong; Sunny Y Wong; Jeremy F Reiter; Mark M Moasser
Journal:  Cancer Res       Date:  2012-12-12       Impact factor: 12.701

7.  Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.

Authors:  Deepak Parashar; Bindu Nair; Anjali Geethadevi; Jasmine George; Ajay Nair; Shirng-Wern Tsaih; Ishaque P Kadamberi; Gopa Kumar Gopinadhan Nair; Yiling Lu; Ramani Ramchandran; Denise S Uyar; Janet S Rader; Prahlad T Ram; Gordon B Mills; Sunila Pradeep; Pradeep Chaluvally-Raghavan
Journal:  Cancer Res       Date:  2020-10-21       Impact factor: 12.701

Review 8.  Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.

Authors:  Shinichi Sakamoto; A Jacqueline Ryan; Natasha Kyprianou
Journal:  J Cell Biochem       Date:  2008-02-15       Impact factor: 4.429

9.  Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.

Authors:  Ashish Garg; Alison W Tisdale; Eman Haidari; Efrosini Kokkoli
Journal:  Int J Pharm       Date:  2008-09-19       Impact factor: 5.875

10.  Bicalutamide inhibits androgen-mediated adhesion of prostate cancer cells exposed to ionizing radiation.

Authors:  Tao Wang; Michael R Alavian; Hira Lal Goel; Lucia R Languino; Thomas J Fitzgerald
Journal:  Prostate       Date:  2008-12-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.